Literature DB >> 6713770

Cimetidine-induced reduction in gastrointestinal absorption of antipyrine and rate constants for formation of its metabolites.

L B Slusher, E S Vesell.   

Abstract

In 15 normal men, cimetidine taken orally in a dose of 300 mg twice a day for 3 days reduced to similar extents the rate constants for formation (ki) of the three principal metabolites of antipyrine (AP): 29.9% +/- 8.5% (mean +/- SD) for 4-hydroxyantipyrine (4-OH-AP); 28.3% +/- 6.3% for 3-hydroxymethylantipyrine (3-OHM-AP); and 22.4% +/- 5.6% for N-demethylantipyrine (NDM-AP). AP clearance declined 24.3%; AP salivary t 1/2 rose 33%; and corrected AP apparent volume of distribution was unchanged. In one apparently normal subject, however, kis for formation of 3-OHM-AP and NDM-AP rose after cimetidine even though AP clearance declined 19.7%. This surprising result, which suggests that cimetidine can exert an inductive effect on the hepatic mixed-function oxidases of some subjects, was checked by restudying the individual. Very similar values occurred on repetition. The average increase in kis for NDM-AP and 3-OHM-AP was 172.2% and 34.0%. These unusual results in this subject indicate that at least two distinguishable forms of cytochrome P-450 participate in AP metabolism in man. Cimetidine appeared to reduce the amount of AP absorbed from the gut in 10 of our 15 normal subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713770     DOI: 10.1038/clpt.1984.79

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  The effects of cimetidine and ranitidine on the pharmacokinetics of cifenline.

Authors:  J W Massarella; T M Defeo; J Liguori; S Passe; K Aogaichi
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

2.  Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.

Authors:  A Anadón; M R Martinez-Larrañaga; M C Fernandez; M J Diaz; P Bringas
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.

Authors:  D Bach; R Blevins; N Kerner; M Rubenfire; D J Edwards
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

4.  Regulation of paracellular absorption of cimetidine and 5-aminosalicylate in rat intestine.

Authors:  S Y Zhou; N Piyapolrungroj; L Pao; C Li; G Liu; E Zimmermann; D Fleisher
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  Absorption of D-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach.

Authors:  Y Wang; R Aun; F L Tse
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

Review 6.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

7.  Pharmacogenetic differences in the inhibitory effect of cimetidine on the metabolism of antipyrine.

Authors:  B Gachályi; A Vas; K Csillag; B Nagy; F Kocsis; A Káldor
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Lack of effect of cimetidine on the pharmacokinetics and metabolism of a single oral dose of metronidazole.

Authors:  S Loft; M Døssing; J Sonne; K Dalhof; K Bjerrum; H E Poulsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Polymorphism of theophylline metabolism in man.

Authors:  C A Miller; L B Slusher; E S Vesell
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

Review 10.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.